KMKonstantin Mayer

Konstantin Mayer

*This is an algorithmically generated author record based on publicly available information.

Konstantin Mayer has a total of 227 co-authors. Here are the top co-authors by number of shared publications:

  • Werner Seeger

    Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC) Member of the German Center for Lung Research (DZL) Giessen Germany

    25 shared publications
  • Matthias Hecker

    Medizinische Klinik II, Universitätsklinikum Gießen und Marburg, Standort Gießen, Mitglied des Deutschen Zentrums für Lungenforschung (DZL), Justus-Liebig-Universität, Gießen, Deutschland

    11 shared publications
  • Friedrich Grimminger

    Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University of Giessen, Aulweg 130, 35392 Giessen, Germany

    8 shared publications
  • Susanne Herold

    Department of Medicine V, Internal Medicine, Infectious Diseases and Infection Control, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), German Center for Infection Research (DZIF), Justus-Liebig-University Giessen (JLU), Giessen, Germany

    7 shared publications
  • Andreas Hecker

    Department of General, Visceral, Thoracic and Transplant Surgery, University Hospital Giessen, Justus-Liebig-University Giessen, Rudolf-Buchheim-Strasse 6, 35392 Giessen, Germany

    6 shared publications
  • István Vadász

    Department of Internal Medicine, Justus Liebig University, Universities of Giessen and Marburg Lung Center, Giessen, Germany

    6 shared publications

Latest Publications

  • Open Access

    Parenteral Nutrition Containing Fish Oil for Hospitalized Non-Intensive Care Unit (ICU) Patients: A Systematic Review, Meta-Analysis, and Cost-Effectiveness Analysis

    by Lorenzo Pradelli, Axel Rüdiger Heller, Stanislaw Klek, Konstantin Mayer, Martin D. Rosenthal, Maurizio Muscaritoli

    Background and aims: We investigated parenteral nutrition (PN) containing fish oil (FO-PN) vs. standard PN without fish oil (NF-PN) in adult patients hospitalized in the non-intensive care unit (general ward). Methods: Searches in Medline, Embase, and Web of Science (any date to 10 October 2024) were screened, data were extracted, and the quality of the studies was assessed by two independent researchers. Meta-analyses were performed, with outcomes included in random effects models, and heterogeneity for clinical outcomes was explored via subgroup analyses and meta-regression. Pharmacoeconomic analyses used data from the current meta-analysis. Results: In this study, 29 randomized controlled trials (RCTs) were included, with intervention and control groups given FO-PN and NF-PN, respectively, as part of PN covering ≥70% energy provision. Compared to NF-PN, FO-PN was associated with a 37% lower relative risk (RR) of infection (19 RCTs; RR 0.63, 95% confidence interval [CI] 0.50–0.78; p < 0.0001), 2.03 days shorter length of hospital stay (18 RCTs; 95% CI 1.23–2.84; p < 0.00001), and a 51% reduction in the risk of sepsis (10 RCTs; RR 0.49, 95% CI 0.32–0.74; p = 0.0009). There was a non-significant 54% reduction in the 30-day mortality rate (11 RCTs; RR 0.46, 95% CI 0.20–1.08; p = 0.07) for FO-PN. FO-PN was associated with better clinical outcomes and financial savings (i.e., dominance) compared to NF-PN in all five countries studied. Conclusions: FO-PN is a cost-effective option compared to NF-PN for adult patients hospitalized in a general ward across a range of healthcare systems.


  • Automated CT Image Processing for the Diagnosis, Prediction, and Differentiation of Phenotypes in Chronic Lung Allograft Dysfunction After Lung Transplantation

    by Stefan Kuhnert, Nermin Halim, Janine Sommerlad, Henning Gall, Athiththan Yogeswaran, Fritz C. Roller, Gabriele Krombach, Martin Reichert, Ingolf Askevold, Andreas Hecker, et al.

    Background: Chronic lung allograft dysfunction (CLAD) after lung transplantation is a common complication with a poor prognosis. We assessed the utility of quantitative computed tomography (CT) for the diagnosis, prediction, and discrimination of CLAD phenotypes.Methods: We retrospectively analyzed routine inspiratory and expiratory CT scans from 78 patients at different time points after lung transplantation. Mean lung density (MLD), parametric response mapping (PRM), percentage of air trapping, and airway wall morphology parameters were calculated using the image processing software YACTA. Diagnostic and predictive utility was determined by receiver operating characteristic analysis and Pearson correlation.Results: Markers of air trapping showed promise for the diagnosis and prediction of bronchiolitis obliterans syndrome (BOS); for example, expiratory MLD showed areas under the curve (AUCs) of 0.905 for diagnosis and 0.729 for 1‐year prediction. For diagnosis of CLAD with mixed phenotype, peripheral measurements (e.g., PRM of peripheral functional small airway disease: AUC 0.893) were most suitable. Markers of airway thickening (e.g., expiratory wall thickness at an inner perimeter of 10 mm: AUC 0.767) gave good diagnostic values for the undefined phenotype. CT biomarkers differed significantly among CLAD phenotypes.Conclusions: Different CT biomarkers are suitable for the diagnosis of CLAD phenotypes, prediction of BOS, and differentiation of CLAD phenotypes.


  • Open Access

    Postoperative Fluid Accumulation is Associated With Underestimation of AKI Severity in Lung Transplant Recipients

    by Stefan Kuhnert, Janine Sommerlad, Henning Gall, Max M. Weder, Matthias Wolff, Sebastian Eberle, Michael Sander, Martin Reichert, Christian Koch, Ingolf Askevold, et al.

    Background: Post‐lung transplantation (LTx) fluid accumulation can lead to dilution of serum creatinine (SCr). We hypothesized that fluid accumulation might impact the diagnosis, staging, and outcome of posttransplant acute kidney injury (AKI).Methods: In this retrospective study, we analyzed data from 131 adult LTx patients at a single German lung center between 2005 and 2018. We assessed the occurrence of AKI within 7 days posttransplant, both before and after SCr‐adjustment for fluid balance (FB), and investigated its impact on all‐cause mortality. Transient and persistent AKIs were defined as return to baseline kidney function or continuation of AKI beyond 72 h of onset, respectively.Results: AKI was diagnosed in 58.8% of patients according to crude SCr values. When considering FB‐adjusted SCr values, AKI severity was underestimated in 20.6% of patients, that is, AKI was detected in an additional 6.9% of patients and led to AKI upstaging in 23.4% of cases. Patients initially underestimated but detected with AKI only after FB adjustment had higher mortality compared to those who did not meet AKI criteria (hazard ratio [HR] 2.98; 95% confidence interval [CI] 1.06, 8.36; p = 0.038). Persistent AKI was associated with higher mortality than transient AKI, regardless of using crude or adjusted SCr values (p < 0.05). Persistent AKI emerged as an independent risk factor for mortality (HR 2.35; 95% CI 1.29, 4.30; p = 0.005).Conclusion: Adjusting for FB and evaluating renal recovery patterns post‐AKI may enhance the sensitivity of AKI detection. This approach could help identify patients with poor prognosis and potentially improve outcomes in lung transplant recipients.Trial Registration: ClinicalTrials.gov identifier: NCT03039959, NCT03046277.


  • Open Access

    Effects of Omega-3 Polyunsaturated Fatty Acids on the Formation of Adipokines, Cytokines, and Oxylipins in Retroperitoneal Adipose Tissue of Mice

    by Tatjana Wenderoth, Martin Feldotto, Jessica Hernandez, Julia Schäffer, Stephan Leisengang, Fabian Johannes Pflieger, Janne Bredehöft, Konstantin Mayer, Jing X. Kang, Jens Bier, et al.

    Oxylipins and specialized pro-resolving lipid mediators (SPMs) derived from polyunsaturated fatty acids (PUFAs) are mediators that coordinate an active process of inflammation resolution. While these mediators have potential as circulating biomarkers for several disease states with inflammatory components, the source of plasma oxylipins/SPMs remains a matter of debate but may involve white adipose tissue (WAT). Here, we aimed to investigate to what extent high or low omega (n)-3 PUFA enrichment affects the production of cytokines and adipokines (RT-PCR), as well as oxylipins/SPMs (liquid chromatography–tandem mass spectrometry) in the WAT of mice during lipopolysaccharide (LPS)-induced systemic inflammation (intraperitoneal injection, 2.5 mg/kg, 24 h). For this purpose, n-3 PUFA genetically enriched mice (FAT-1), which endogenously synthesize n-3 PUFAs, were compared to wild-type mice (WT) and combined with n-3 PUFA-sufficient or deficient diets. LPS-induced systemic inflammation resulted in the decreased expression of most adipokines and interleukin-6 in WAT, whereas the n-3-sufficient diet increased them compared to the deficient diet. The n-6 PUFA arachidonic acid was decreased in WAT of FAT-1 mice, while n-3 derived PUFAs (eicosapentaenoic acid, docosahexaenoic acid) and their metabolites (oxylipins/SPMs) were increased in WAT by genetic and nutritional n-3 enrichment. Several oxylipins/SPMs were increased by LPS treatment in WAT compared to PBS-treated controls in genetically n-3 enriched FAT-1 mice. Overall, we show that WAT may significantly contribute to circulating oxylipin production. Moreover, n-3-sufficient or n-3-deficient diets alter adipokine production. The precise interplay between cytokines, adipokines, and oxylipins remains to be further investigated.


  • Intensivtherapie im Rahmen der Transplantation solider Organe

    by Christoph Lichtenstern, Frederike Lund, Matthias Müller, Jan Schmidt, Konstantin Mayer, Markus A. Weigand

  • Open Access

    n-3 Polyunsaturated Fatty Acids Modulate LPS-Induced ARDS and the Lung–Brain Axis of Communication in Wild-Type versus Fat-1 Mice Genetically Modified for Leukotriene B4 Receptor 1 or Chemerin Receptor 23 Knockout

    by Jessica Hernandez, Julia Schäffer, Christiane Herden, Fabian Johannes Pflieger, Sylvia Reiche, Svenja Körber, Hiromu Kitagawa, Joelle Welter, Susanne Michels, Carsten Culmsee, et al.

    Specialized pro-resolving mediators (SPMs) and especially Resolvin E1 (RvE1) can actively terminate inflammation and promote healing during lung diseases such as acute respiratory distress syndrome (ARDS). Although ARDS primarily affects the lung, many ARDS patients also develop neurocognitive impairments. To investigate the connection between the lung and brain during ARDS and the therapeutic potential of SPMs and its derivatives, fat-1 mice were crossbred with RvE1 receptor knockout mice. ARDS was induced in these mice by intratracheal application of lipopolysaccharide (LPS, 10 µg). Mice were sacrificed at 0 h, 4 h, 24 h, 72 h, and 120 h post inflammation, and effects on the lung, liver, and brain were assessed by RT-PCR, multiplex, immunohistochemistry, Western blot, and LC-MS/MS. Protein and mRNA analyses of the lung, liver, and hypothalamus revealed LPS-induced lung inflammation increased inflammatory signaling in the hypothalamus despite low signaling in the periphery. Neutrophil recruitment in different brain structures was determined by immunohistochemical staining. Overall, we showed that immune cell trafficking to the brain contributed to immune-to-brain communication during ARDS rather than cytokines. Deficiency in RvE1 receptors and enhanced omega-3 polyunsaturated fatty acid levels (fat-1 mice) affect lung–brain interaction during ARDS by altering profiles of several inflammatory and lipid mediators and glial activity markers.


  • Intensivtherapie im Rahmen der Transplantation solider Organe

    by Christoph Lichtenstern, Frederike Lund, Matthias Müller, Jan Schmidt, Konstantin Mayer, Markus A. Weigand

  • Open Access

    Omega-3 fatty acids in parenteral nutrition – A systematic review with network meta-analysis on clinical outcomes

    by Lorenzo Pradelli, Konstantin Mayer, Stanislaw Klek, Martin D. Rosenthal, Massimiliano Povero, Axel R. Heller, Maurizio Muscaritoli


  • Open Access

    Correction: Sommer et al. Decreased Thymic Output Contributes to Immune Defects in Septic Patients. J. Clin. Med. 2020, 9, 2695

    by Natascha Sommer, Steffen Noack, Andreas Hecker, Holger Hackstein, Gregor Bein, Norbert Weissmann, Werner Seeger, Konstantin Mayer, Matthias Hecker

    In the original article, there were errors in Figure 1D (panel CD8-Control)